{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T12:51:20Z","timestamp":1648731080458},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Drug Policy"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1016\/j.drugpo.2011.03.008","type":"journal-article","created":{"date-parts":[[2011,5,24]],"date-time":"2011-05-24T04:05:50Z","timestamp":1306209950000},"page":"226-232","source":"Crossref","is-referenced-by-count":1,"title":["Estimating national-level syringe availability to injecting drug users and injection coverage: Switzerland, 1996\u20132006"],"prefix":"10.1016","volume":"22","author":[{"given":"Sophie","family":"Arnaud","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9","family":"Jeannin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7oise","family":"Dubois-Arber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugpo.2011.03.008_bib0005","first-page":"804","article-title":"Evolution de la consommation et des pratiques \u00e0 risques de transmission du VIH et du VHC chez les consommateurs de drogue par injection en Suisse, 1993\u20132006","volume":"45","author":"Balthasar","year":"2007","journal-title":"Bulletin de l\u2019Office F\u00e9d\u00e9ral de la Sant\u00e9 Publique"},{"issue":"2\u20133","key":"10.1016\/j.drugpo.2011.03.008_bib0010","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.drugalcdep.2006.12.035","article-title":"Higher syringe coverage is associated with lower odds of HIV risk and does not increase unsafe syringe disposal among syringe exchange program clients","volume":"89","author":"Bluthenthal","year":"2007","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.drugpo.2011.03.008_bib0015","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1111\/j.1360-0443.2004.00694.x","article-title":"Sterile syringe access conditions and variations in HIV risk among drug injectors in three cities","volume":"99","author":"Bluthenthal","year":"2004","journal-title":"Addiction"},{"issue":"4","key":"10.1016\/j.drugpo.2011.03.008_bib0020","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1360-0443.2006.01741.x","article-title":"Examination of the association between syringe exchange program (SEP) dispensation policy and SEP client-level syringe coverage among injection drug users","volume":"102","author":"Bluthenthal","year":"2007","journal-title":"Addiction"},{"key":"10.1016\/j.drugpo.2011.03.008_bib0025","series-title":"Enqu\u00eate nationale des pharmacies 1997","author":"Chollet-Bornand","year":"1997"},{"key":"10.1016\/j.drugpo.2011.03.008_bib0030","series-title":"Preventing HIV infection among injecting drug users in high-risk countries. An assessment of the evidence","author":"Committee on the prevention of HIV infection among injecting drug users in high-risk countries.","year":"2006"},{"issue":"21","key":"10.1016\/j.drugpo.2011.03.008_bib0035","first-page":"1","article-title":"Trends in drug consumption and risk of transmission of HIV and hepatitis C virus among injecting drug users in Switzerland, 1993-2006","volume":"13","author":"Dubois-Arber","year":"2008","journal-title":"Euro Surveillance"},{"key":"10.1016\/j.drugpo.2011.03.008_bib0040","series-title":"Implementing the Dublin declaration on partnership to fight HIV\/AIDS in Europe and Central Asia: 2010 progress report (10.2900\/31283 No. 978-92-9193-214-6)","author":"European Centre for Disease Prevention and Control","year":"2010"},{"issue":"6","key":"10.1016\/j.drugpo.2011.03.008_bib0045","first-page":"503","article-title":"From margin to mainstream: The evolution of harm reduction responses to problem drug use in Europe","volume":"15","author":"Hedrich","year":"2008","journal-title":"Drugs: Education, Prevention and Policy"},{"issue":"Suppl. 1","key":"10.1016\/j.drugpo.2011.03.008_bib0050","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/j.drugpo.2007.12.004","article-title":"Community coverage and HIV prevention: Assessing metrics for estimating HIV incidence through syringe exchange","volume":"19","author":"Heimer","year":"2008","journal-title":"The International Journal on Drug Policy"},{"key":"10.1016\/j.drugpo.2011.03.008_bib0055","doi-asserted-by":"crossref","DOI":"10.1186\/1477-7517-6-1","article-title":"The syringe gap: An assessment of sterile syringe need and acquisition among syringe exchange program participants in New York City","volume":"6","author":"Heller","year":"2009","journal-title":"Harm Reduction Journal"},{"issue":"1","key":"10.1016\/j.drugpo.2011.03.008_bib0060","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ypmed.2009.04.014","article-title":"The influence of needle exchange programs on injection risk behaviors and infection with hepatitis C virus among young injection drug users in select cities in the United States, 1994\u20132004","volume":"49","author":"Holtzman","year":"2009","journal-title":"Preventive Medicine"},{"key":"10.1016\/j.drugpo.2011.03.008_bib0065","series-title":"Analyse de la statistique des traitements \u00e0 la m\u00e9thadone dans le canton de Vaud. P\u00e9riode 2001\u20132008","author":"Huissoud","year":"2009"},{"key":"10.1016\/j.drugpo.2011.03.008_bib0070","series-title":"Studie zur Spritzenabgabe durch Apotheken","author":"IPSO Sozialforschung","year":"1995"},{"key":"10.1016\/j.drugpo.2011.03.008_bib0075","series-title":"Syst\u00e8me de suivi de la strat\u00e9gie de la lutte contre le VIH\/sida en Suisse: Rapport de synth\u00e8se 2004\u20132008","author":"Jeannin","year":"2009"},{"key":"10.1016\/j.drugpo.2011.03.008_bib0080","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000070984","article-title":"Estimated trends in the prevalence of heroin addiction in Switzerland: A multiple-indicator approach","volume":"9","author":"Maag","year":"2003","journal-title":"European Addiction Research"},{"key":"10.1016\/j.drugpo.2011.03.008_bib0085","first-page":"1","article-title":"Die epidemiologische Entwicklung des Heroinkonsums\u2014schweizerische und internationale Trends","volume":"1","author":"Maag","year":"2004","journal-title":"Abh\u00e4ngigkeiten"},{"issue":"3","key":"10.1016\/j.drugpo.2011.03.008_bib0090","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s11524-006-9139-1","article-title":"The impact of legalizing syringe exchange programs on arrests among injecting drug users in California","volume":"84","author":"Martinez","year":"2007","journal-title":"Journal of Urban Health"},{"issue":"9719","key":"10.1016\/j.drugpo.2011.03.008_bib0095","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/S0140-6736(10)60232-2","article-title":"HIV prevention, treatment and care for people who inject drugs: A systematic review of global, regional and national coverage","volume":"375","author":"Mathers","year":"2010","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.drugpo.2011.03.008_bib0100","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s11524-008-9271-1","article-title":"Greater drug injecting risk for HIV, HBV, and HCV infection in a city where syringe exchange and pharmacy syringe distribution are illegal","volume":"85","author":"Neaigus","year":"2008","journal-title":"Journal of Urban Health"},{"key":"10.1016\/j.drugpo.2011.03.008_bib0105","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/S0140-6736(06)68804-1","article-title":"Incidence of heroin use in Zurich, Switzerland: A treatment case register analysis","volume":"367","author":"Nordt","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.drugpo.2011.03.008_bib0110","series-title":"Les traitements avec prescription d\u2019h\u00e9ro\u00efne\/de diac\u00e9tylmorphine (HeGeBe) en 2006","author":"Office f\u00e9d\u00e9ral de la sant\u00e9 publique (OFSP)","year":"2007"},{"key":"10.1016\/j.drugpo.2011.03.008_bib0115","unstructured":"Office f\u00e9deral de la sant\u00e9 publique (OFSP). (2010). Caract\u00e9ristiques de l\u2019\u00e9pid\u00e9mie de VIH\/sida en Suisse 2009."},{"issue":"5","key":"10.1016\/j.drugpo.2011.03.008_bib0120","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/j.1360-0443.2009.02888.x","article-title":"Evidence for the effectiveness of harm reduction interventions in preventing hepatitis C transmission among injecting drug users: A review of reviews","volume":"105","author":"Palmateer","year":"2010","journal-title":"Addiction"},{"key":"10.1016\/j.drugpo.2011.03.008_bib0125","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.drugalcdep.2007.05.026","article-title":"Modelling the hepatitis C virus epidemic in Australia","volume":"91","author":"Razali","year":"2007","journal-title":"Drug & Alcohol Dependence"},{"key":"10.1016\/j.drugpo.2011.03.008_bib0130","series-title":"Remise de seringues et de traitements \u00e0 la m\u00e9thadone pour les personnes toxicomanes","author":"Samitca","year":"2006"},{"issue":"Suppl. 1","key":"10.1016\/j.drugpo.2011.03.008_bib0135","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.drugpo.2007.11.008","article-title":"Access to syringes in three Russian cities: Implications for syringe distribution and coverage","volume":"19","author":"Sarang","year":"2008","journal-title":"The International journal on drug policy"},{"issue":"2","key":"10.1016\/j.drugpo.2011.03.008_bib0140","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.drugpo.2006.11.012","article-title":"Coverage of HIV prevention programmes for injection drug users: Confusions, aspirations, definitions and ways forward","volume":"18","author":"Sharma","year":"2007","journal-title":"The International Journal on Drug Policy"},{"issue":"Suppl. 1","key":"10.1016\/j.drugpo.2011.03.008_bib0145","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.drugpo.2007.11.011","article-title":"Correlates of syringe coverage for heroin injection in 35 large metropolitan areas in the US in which heroin is the dominant injected drug","volume":"19","author":"Tempalski","year":"2008","journal-title":"The International Journal on Drug Policy"},{"issue":"4","key":"10.1016\/j.drugpo.2011.03.008_bib0150","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1001\/jama.284.4.450","article-title":"The natural history of hepatitis C virus infection: Host, viral, and environmental factors","volume":"284","author":"Thomas","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.drugpo.2011.03.008_bib0155","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000259046","article-title":"Harm reduction: The case of Switzerland","volume":"1","author":"Uchtenhagen","year":"1995","journal-title":"European Addiction Research"},{"issue":"9","key":"10.1016\/j.drugpo.2011.03.008_bib0160","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1111\/j.1360-0443.2007.01912.x","article-title":"Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: Evidence from the Amsterdam Cohort Studies among drug users","volume":"102","author":"van den Berg","year":"2007","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.drugpo.2011.03.008_bib0165","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/01.qai.0000219788.73539.47","article-title":"Model projections on the required coverage of syringe distribution to prevent HIV epidemics among injecting drug users","volume":"42","author":"Vickerman","year":"2006","journal-title":"JAIDS-Journal of Acquired Immune Deficiency Syndromes"},{"issue":"26","key":"10.1016\/j.drugpo.2011.03.008_bib0170","article-title":"Injecting drug use in Europe: Stable or declining","volume":"15","author":"Wiessing","year":"2010","journal-title":"Euro Surveillance: Bulletin Europeen sur les Maladies Transmissibles=European Communicable Disease Bulletin"},{"issue":"6","key":"10.1016\/j.drugpo.2011.03.008_bib0175","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.2105\/AJPH.2008.141846","article-title":"Associations between availability and coverage of HIV-prevention measures and subsequent incidence of diagnosed HIV infection among injecting drug users","volume":"99","author":"Wiessing","year":"2009","journal-title":"American Journal of Public Health"},{"key":"10.1016\/j.drugpo.2011.03.008_bib0180","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1080\/10826080600669579","article-title":"Do needle syringe programs reduce HIV infection among injecting drug users: A comprehensive review of the international evidence","volume":"41","author":"Wodak","year":"2006","journal-title":"Substance Use & Misuse"},{"key":"10.1016\/j.drugpo.2011.03.008_bib0185","series-title":"WHO, UNODC, UNAIDS technical guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users","author":"World Health Organization (WHO)","year":"2009"},{"key":"10.1016\/j.drugpo.2011.03.008_bib0190","series-title":"Evaluation of the Confederation's measures to reduce drug-related problems: Fourth synthesis report 1999\u20132002","author":"Zobel","year":"2003"}],"container-title":["International Journal of Drug Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395911000533?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395911000533?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,2]],"date-time":"2018-12-02T14:22:04Z","timestamp":1543760524000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955395911000533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S0955395911000533"],"URL":"https:\/\/doi.org\/10.1016\/j.drugpo.2011.03.008","relation":{},"ISSN":["0955-3959"],"issn-type":[{"value":"0955-3959","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}